MATTISSE Trademark

Trademark Overview


On Friday, July 5, 2024, a trademark application was filed for MATTISSE with the United States Patent and Trademark Office. The USPTO has given the MATTISSE trademark a serial number of 79405140. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 12, 2025. This trademark is owned by LATTICE MEDICAL. The MATTISSE trademark is filed in the Medical Instrument Products category with the following description:

3D-printed bioabsorbable implant for breast reconstruction.
mattisse

General Information


Serial Number79405140
Word MarkMATTISSE
Filing DateFriday, July 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, February 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services3D-printed bioabsorbable implant for breast reconstruction.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, September 26, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLATTICE MEDICAL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, September 26, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2024APPLICATION FILING RECEIPT MAILED
Sunday, December 29, 2024ASSIGNED TO EXAMINER
Friday, January 3, 2025NON-FINAL ACTION WRITTEN
Saturday, January 4, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 12, 2025REFUSAL PROCESSED BY MPU
Wednesday, February 12, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB